The use and development of germline polymorphisms in clinical oncology
- PMID: 15173210
- DOI: 10.1200/JCO.2004.04.900
The use and development of germline polymorphisms in clinical oncology
Comment on
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.J Clin Oncol. 2004 Jul 1;22(13):2594-601. doi: 10.1200/JCO.2004.08.067. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173214 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
